OncoHealth
Iris virtual oncology navigation and supportive care

OncoHealth’s Iris program connects people with cancer and caregivers to virtual oncology nursing, mental health, nutrition, and practical navigation support.
Best for
- Health plans and employers adding supportive oncology care between treatment visits
- Eligible people with cancer and caregivers needing continuing specialist support
Not ideal for
- People seeking a replacement for their treating oncologist or emergency care
- Buyers evaluating only prior authorization without a supportive-care requirement

Bottom line
OncoHealth’s Iris is a useful option for organizations seeking specialist cancer support beyond treatment appointments. Its value is the combination of oncology nursing, emotional support, nutrition, and navigation within a continuing care benefit.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
OncoHealth’s Iris program serves health plans, employers, and eligible people living with cancer who need help outside the treatment appointment. Its support spans symptom questions, emotional needs, nutrition, and practical navigation. Thyme Care is a relevant alternative for virtual oncology navigation and supportive care, with different contracting and provider-coordination arrangements.
The purchase is a contracted care benefit, not a general wellness subscription. OncoHealth also operates oncology utilization-management services, but those do not fully describe Iris. A buyer comparing supportive care should identify which clinical services, engagement work, and coordination responsibilities are included in the benefit.
- Outcomes and workflow value (7.8): A defined national supportive-care service and payer distribution support a concrete access use case.
- Product and service depth (8.2): Oncology nursing, therapy, nutrition, and navigation address several needs outside treatment visits.
- Ease of implementation (7.4): Web, app, and phone access reduce channel barriers, while eligibility and coordination with treating clinicians remain necessary.
- Pricing clarity (6.0): Payer and employer terms are contracted; no universal Iris dollar price is provided.
What Iris Adds Between Treatment Visits
The October 2026 Iris announcement describes 24/7 access to oncology-trained nurses, with licensed mental health therapists and registered dietitians supporting broader emotional and nutritional needs. Members and caregivers can use the web, an app, or the phone. The service is available across all 50 states, subject to participation and eligibility.
This can give a person a route to help when side effects, worries, or everyday questions arise at home. It complements treatment delivered by the oncology practice. Urgent problems and treatment decisions still require appropriate escalation and coordination with the treating clinical team.
Navigation and Utilization Management Are Different
OncoHealth’s broader business includes management of oncology cost and complexity. A prior-authorization or utilization-management function helps assess treatment coverage and appropriateness within a payer process. Supportive care addresses the person’s clinical, emotional, nutritional, and practical needs beyond that process.
The distinction matters when comparing OncoHealth with Thyme Care. Iris is a relevant supportive-care alternative, while a contract limited to authorization work would not replace the same service. Purchasers should specify how members enter the program and how supportive-care information reaches their existing oncology clinicians.
Access, Evidence, and Service Continuity
On October 8, 2026, Iris joined Solera Health’s Cancer Care Network, creating an additional route through participating health plans and employers. That is evidence of distribution expansion and current service availability. It is not proof that every covered member has enrolled or that all plans offer identical benefits.
A purchaser seeking a measurable reduction in emergency visits or total cancer spending should assess the relevant outcome evidence and population separately. Availability of support alone does not establish a guaranteed financial or clinical result.
Product and service details: oncohealth.us, oncohealth.us.
Company scale
Growjo estimates OncoHealth’s annual revenue at $36.2 million. Scale source
What People Say
What people like
"I want to reach an oncology nurse when a question comes up between appointments."
"Being able to discuss food and emotional concerns with specialists would make the support more useful."
What people don't like
"I still need to confirm that my health plan offers Iris and how it works with my oncology team."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.
Based on: Product or service details, Product or service details.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| OncoHealth | 7.6 | 7.4 |
| Thyme Care | 7.6 | 7.2 |
| Reimagine Care | 7.6 | 7.1 |
Pricing
| Item | Detail |
|---|---|
| Access model | Contracted through participating health plans and employers; eligibility applies. |
| Iris rate | No universal public dollar rate. |
| Service scope | Confirm nursing availability, therapy and nutrition access, caregiver support, enrollment, and clinical escalation. |
| Solera distribution | Available in Solera’s Cancer Care Network from October 8, 2026, subject to participation and eligibility. |
Leadership
Recent news
- October 2026: Iris by OncoHealth joined Solera Health’s Cancer Care Network, expanding distribution through participating health plans and employers.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- oncohealth.us · iris by oncohealth joins solera healths new cancer care network to expand access to oncology support
- oncohealth.us · oncohealth appoints jon maack as chief executive officer to lead next phase of growth
- growjo.com · company/OncoHealth
- oncohealth.us · executive leadership team
